- Home
- PRFX vs IBG Comparison
PRFX vs IBG Comparison
Compare PRFX & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRFX | IBG |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | Israel | Australia |
| Employees | N/A | 9 |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 2.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRFX | IBG |
|---|---|---|
| Price | $2.29 | $1.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.2K | ★ 666.6K |
| Earning Date | 04-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.58 | $0.30 |
| 52 Week High | $3.71 | $6.50 |
Technical Indicators
Market Signals| Indicator | PRFX | IBG |
|---|---|---|
| Relative Strength Index (RSI) | 44.65 | 34.67 |
| Support Level | $1.28 | $0.49 |
| Resistance Level | $3.65 | $1.75 |
| Average True Range (ATR) | 0.22 | 0.57 |
| MACD | -0.12 | -0.36 |
| Stochastic Oscillator | 11.08 | 4.48 |
Price Performance
Historical ComparisonAbout PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.